Epidemiology — MCQs

If a Hemoccult test is negative for screening of colonic cancer, no further test is done. If the Hemoccult test is positive, the individual will have a second stool sample tested with Hemoccult II test. If this second sample is positive for blood, the individual will be referred for more extensive evaluation. What is the effect of this screening method on net sensitivity and net specificity?

Q1014Easy

What is the first step in the investigation of an epidemic?

Q1015Easy

Under AFP Surveillance, what is the follow-up examination period for residual paralysis?

Q1016Easy

What is the most common cancer affecting both males and females worldwide?

Q1017Medium

Which of the following is NOT evaluated by a cohort study?

Q1018Medium

In a school with 100 unimmunized children, 1 child developed measles on January 1st. Following this, 35 children developed measles, with 3 cases occurring on January 3rd and the remaining cases appearing 2-3 weeks later. What is the secondary attack rate (SAR)?

Q1019Easy

The usefulness of a screening test in a community depends on its:

Q1020Medium

What is the definition of 'lead time' in epidemiology?

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1011: Formation of an etiological hypothesis is a key step in which type of epidemiology?

A. Descriptive Epidemiology (Correct Answer)
B. Analytical Epidemiology
C. Experimental Epidemiology
D. None of the above

Explanation: ### Explanation The correct answer is **Descriptive Epidemiology**. #### 1. Why Descriptive Epidemiology is Correct Descriptive epidemiology is the first step in an epidemiological investigation. It involves the systematic collection and analysis of data to describe the occurrence of a disease in terms of **Time, Place, and Person**. * **The Core Concept:** By observing who is getting the disease, where it is occurring, and when it is peaking, epidemiologists can identify patterns. These patterns allow for the **formulation of an etiological hypothesis** (a "best guess" regarding the cause or risk factors of the disease). You cannot test a hypothesis until you have first formed one through descriptive observation. #### 2. Why Other Options are Incorrect * **Analytical Epidemiology:** This is the second step. Its primary purpose is to **test the hypothesis** formulated during the descriptive phase. It uses comparison groups (e.g., Case-Control or Cohort studies) to determine if there is a statistically significant association between an exposure and an outcome. * **Experimental Epidemiology:** This involves **confirming the hypothesis** and measuring the effectiveness of interventions (e.g., Randomized Controlled Trials). Here, the investigator has direct control over the assignment of exposure. #### 3. Clinical Pearls & High-Yield Facts for NEET-PG * **Sequence of Investigation:** Descriptive (Hypothesis **Formation**) $\rightarrow$ Analytical (Hypothesis **Testing**) $\rightarrow$ Experimental (Hypothesis **Confirmation**). * **Descriptive Epidemiology** provides clues to etiology but cannot establish a "cause-and-effect" relationship. * **Key Question Addressed:** Descriptive epidemiology asks *"Who, Where, and When?"* while Analytical epidemiology asks *"How and Why?"* * **Cross-sectional studies** are often considered the bridge between descriptive and analytical epidemiology but are primarily descriptive when used to calculate prevalence.

Question 1012: Randomization is useful to eliminate which of the following?

A. Observer bias
B. Confounding factors (Correct Answer)
C. Patient bias
D. Sampling bias

Explanation: **Explanation:** **Why Confounding Factors is Correct:** Randomization is the "heart" of a Randomized Controlled Trial (RCT). Its primary purpose is to ensure that both known and unknown **confounding factors** are distributed equally between the study and control groups. By allocating participants purely by chance, randomization eliminates **selection bias** and balances prognostic factors, ensuring that any observed difference in outcome is due to the intervention alone and not an extraneous variable. It is the only method that can control for **unknown confounders**. **Why Other Options are Incorrect:** * **A & C (Observer and Patient Bias):** These are types of information/measurement bias. Randomization does not prevent these; they are eliminated through **Blinding** (Masking). Blinding ensures that neither the patient nor the researcher knows who is receiving the treatment, thus preventing subjective prejudice. * **D (Sampling Bias):** This occurs when the study population is not representative of the target population. It is eliminated through **Random Sampling** (e.g., simple random sampling), not Randomization (Random Allocation). **High-Yield Clinical Pearls for NEET-PG:** * **Randomization** = Eliminates Confounding + Selection Bias. * **Blinding** = Eliminates Observer + Patient (Information) Bias. * **Matching** = A technique used in Case-Control studies to eliminate known confounders (but cannot control for unknown ones). * **The "Gold Standard"** for testing a new drug is the Double-Blind Randomized Controlled Trial. * **Confounding by Indication:** A specific type of bias where the factor that dictates the treatment choice is also related to the outcome.

Question 1013: If a Hemoccult test is negative for screening of colonic cancer, no further test is done. If the Hemoccult test is positive, the individual will have a second stool sample tested with Hemoccult II test. If this second sample is positive for blood, the individual will be referred for more extensive evaluation. What is the effect of this screening method on net sensitivity and net specificity?

A. Net sensitivity and net specificity are both increased.
B. Net sensitivity is decreased and net specificity is increased. (Correct Answer)
C. Net sensitivity is increased and net specificity is decreased.
D. Net sensitivity remains the same and net specificity is increased.

Explanation: ### Explanation This question describes **Screening in Series** (Sequential Testing). In this method, a second test is performed only if the first test result is positive. An individual is considered "positive" only if **both** tests are positive. #### 1. Why the Correct Answer is Right * **Net Sensitivity Decreases:** Sensitivity is the ability to identify true cases. In serial testing, a person must pass two "filters." If a true case tests negative on the first test OR negative on the second test, they are missed. This stricter criteria for a positive result inevitably leads to more false negatives, thereby decreasing net sensitivity. * **Net Specificity Increases:** Specificity is the ability to identify those without the disease. By requiring two consecutive positive results, the chance of a "False Positive" is significantly reduced. Only those who are truly positive (or very likely to be) pass both stages, which enhances the net specificity. #### 2. Why Other Options are Wrong * **Option A & C:** Net sensitivity can never increase in serial testing; it only increases in **Parallel Testing** (where a positive result on *either* test counts as a positive). * **Option D:** Sensitivity cannot remain the same because the second test acts as an additional hurdle that some true cases will fail to clear due to the inherent error margins of any diagnostic tool. #### 3. High-Yield Clinical Pearls for NEET-PG * **Serial Testing (Sequential):** Used when the definitive test is expensive or invasive (e.g., Screening with ELISA followed by Western Blot for HIV). **Goal:** Increase Specificity (reduce false positives). * **Parallel Testing (Simultaneous):** Used in emergency settings or when missing a diagnosis is fatal (e.g., EKG and Cardiac Enzymes for MI). **Goal:** Increase Sensitivity (reduce false negatives). * **Formula Tip:** * Net Sensitivity (Series) = $Sens_1 \times Sens_2$ * Net Specificity (Series) = $Spec_1 + Spec_2 - (Spec_1 \times Spec_2)$

Question 1014: What is the first step in the investigation of an epidemic?

A. Source identification
B. Verification of the diagnosis (Correct Answer)
C. Confirmation of the existence of an epidemic
D. Formation of a hypothesis

Explanation: ### Explanation In epidemiology, the investigation of an outbreak follows a systematic, step-by-step sequence. The **first step** is always the **Verification of the Diagnosis**. #### Why "Verification of the Diagnosis" is Correct Before mobilizing resources or declaring an emergency, it is essential to ensure that the reported cases are accurately diagnosed. This involves clinical examination of cases and laboratory confirmation (where possible) to rule out misdiagnosis or reporting errors. You cannot investigate an outbreak if you are not certain what disease you are investigating. #### Analysis of Incorrect Options * **C. Confirmation of the existence of an epidemic:** This is the **second step**. Once the diagnosis is verified, the investigator compares the current number of cases with the "normal" expected incidence for that area and time to determine if an actual outbreak is occurring. * **D. Formation of a hypothesis:** This occurs much later in the sequence (usually Step 6). A hypothesis regarding the source, mode of transmission, and exposure can only be formulated after descriptive data (Time, Place, Person) has been collected and analyzed. * **A. Source identification:** This is the ultimate goal of the investigation but is part of the later analytical stages. It cannot be done without first defining the disease and the population at risk. #### NEET-PG High-Yield Pearls * **Sequence of Steps (Simplified):** 1. Verification of diagnosis 2. Confirmation of existence 3. Defining the population at risk 4. Rapid search for all cases 5. Descriptive epidemiology (Time, Place, Person) 6. Hypothesis formulation 7. Hypothesis testing 8. Evaluation of control measures 9. Reporting. * **Definition of Epidemic:** The occurrence of cases of an illness in a community or region clearly in excess of normal expectancy. * **Note:** If "Verification of Diagnosis" is not in the options, "Confirmation of existence" is often the next best choice.

Question 1015: Under AFP Surveillance, what is the follow-up examination period for residual paralysis?

A. 15 days from onset of paralysis
B. 33 days from onset of paralysis
C. 60 days from onset of paralysis (Correct Answer)
D. 90 days from onset of paralysis

Explanation: ### Explanation **1. Why Option C is Correct:** Under the Global Polio Eradication Initiative and the National Polio Surveillance Project (NPSP), the standard protocol for **Acute Flaccid Paralysis (AFP) Surveillance** requires a follow-up clinical examination **60 days after the onset of paralysis**. The underlying medical concept is to differentiate between transient paralysis and **Residual Paralysis**. In cases of Wild Poliovirus infection, the motor neuron damage is often permanent, leading to residual weakness that persists beyond 60 days. If the paralysis has resolved by this time, the case is less likely to be Polio and more likely to be a condition like Guillain-Barré Syndrome (GBS) or transverse myelitis. **2. Why Other Options are Incorrect:** * **Option A (15 days):** This is irrelevant to residual paralysis. However, **"Adequate Stool Samples"** must be collected within 14 days of the onset of paralysis. * **Option B (33 days):** This is a distractor with no significance in the AFP surveillance timeline. * **Option D (90 days):** While some neurological recovery can continue for months, the 60-day mark is the internationally standardized "gold standard" for classifying a case as having residual paralysis for surveillance reporting. **3. High-Yield Clinical Pearls for NEET-PG:** * **Case Definition of AFP:** Any child <15 years with sudden onset of flaccid paralysis, or a person of any age if Polio is suspected. * **Stool Collection:** Two samples, 24 hours apart, within 14 days of onset ("Adequate samples"). * **Virological Classification:** A case is confirmed as Polio only if Wild Poliovirus (WPV) or Vaccine-Derived Poliovirus (VDPV) is isolated from stool. * **Non-Polio AFP Rate:** A key indicator of surveillance quality; it should be at least **2 per 100,000** children <15 years.

Question 1016: What is the most common cancer affecting both males and females worldwide?

A. Cancer of the pancreas
B. Buccal mucosa cancer
C. Lung cancer (Correct Answer)
D. Colo-rectal cancer

Explanation: **Explanation:** The correct answer is **Lung Cancer**. According to the latest **GLOBOCAN** data (published by the WHO/IARC), lung cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related mortality globally when considering both sexes combined. **Why Lung Cancer is Correct:** Lung cancer accounts for approximately 12.4% of all new cancer cases worldwide. While Breast cancer has recently surpassed Lung cancer as the most common cancer in *females*, when the data for **both males and females are aggregated**, Lung cancer retains the top position due to its high prevalence in men and rising incidence in women. **Analysis of Incorrect Options:** * **A. Cancer of the Pancreas:** While highly lethal with a poor prognosis, it does not rank among the top five most common cancers globally. * **B. Buccal Mucosa Cancer:** This is a subset of Oral Cancer. While it is highly prevalent in specific regions like **India** (due to tobacco and betel nut chewing), it is not the most common cancer on a global scale. * **D. Colo-rectal Cancer:** This is currently the third most common cancer worldwide. While its incidence is rising due to Westernized diets and sedentary lifestyles, it still trails behind Lung and Breast cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Global (Both Sexes):** Most common = Lung Cancer; Leading cause of death = Lung Cancer. * **Global (Females):** Most common = Breast Cancer. * **India (Both Sexes):** Most common = Breast Cancer (followed by Lip/Oral cavity). * **India (Males):** Most common = Lip and Oral Cavity cancer. * **India (Females):** Most common = Breast Cancer (followed by Cervical cancer). * **Screening:** Low-dose CT (LDCT) is the recommended screening tool for high-risk smokers for lung cancer.

Question 1017: Which of the following is NOT evaluated by a cohort study?

A. Incidence
B. Attributable risk
C. Relative risk
D. Odds ratio (Correct Answer)

Explanation: **Explanation** In epidemiology, the choice of study design dictates which measures of association can be calculated. A **Cohort Study** is a longitudinal, prospective study that starts with a group of exposed and non-exposed individuals and follows them over time to observe the development of an outcome. **Why Odds Ratio is the Correct Answer:** The **Odds Ratio (OR)** is the primary measure of association used in **Case-Control studies**. It estimates the odds of exposure among cases compared to controls. While OR can be calculated in a cohort study, it is not the standard or intended evaluation metric because cohort studies allow for the direct calculation of risk. **Analysis of Incorrect Options:** * **A. Incidence:** Cohort studies are the only observational design that can directly calculate incidence (the number of new cases in a population at risk) because they follow subjects from a healthy state to the onset of disease. * **B. Attributable Risk (AR):** AR measures the impact of an exposure (Incidence in exposed – Incidence in non-exposed). Since cohort studies provide incidence, AR can be easily derived. * **C. Relative Risk (RR):** Also known as Risk Ratio, this is the hallmark measure of a cohort study. It compares the incidence of disease in the exposed group to the incidence in the non-exposed group. **High-Yield Clinical Pearls for NEET-PG:** * **Cohort Study:** Proceeds from **Cause to Effect**. Best for rare exposures. * **Case-Control Study:** Proceeds from **Effect to Cause**. Best for rare diseases. * **Incidence** can *only* be calculated in Cohort studies (and Randomized Controlled Trials). * If a disease is rare, the Odds Ratio (from a case-control study) numerically approximates the Relative Risk.

Question 1018: In a school with 100 unimmunized children, 1 child developed measles on January 1st. Following this, 35 children developed measles, with 3 cases occurring on January 3rd and the remaining cases appearing 2-3 weeks later. What is the secondary attack rate (SAR)?

A. 35%
B. 33.30% (Correct Answer)
C. 32%
D. 36.50%

Explanation: ### Explanation **1. Understanding the Secondary Attack Rate (SAR)** The Secondary Attack Rate measures the spread of a disease among susceptible contacts within the incubation period following exposure to a primary case. It is a measure of **communicability**. The formula for SAR is: $$\text{SAR} = \frac{\text{Number of exposed persons developing the disease within the incubation period}}{\text{Total number of susceptible contacts}} \times 100$$ **2. Calculation for this Case** * **Total Population:** 100 unimmunized (susceptible) children. * **Primary Case:** 1 child (Jan 1st). This child is the source, not a secondary case. * **Susceptible Contacts:** $100 - 1 = 99$ children. * **Co-primary Cases:** The 3 cases occurring on Jan 3rd. Since the incubation period for Measles is ~10–14 days, these children were likely infected by the same source as the first child, not by the first child himself. They are excluded from the numerator. * **Secondary Cases:** $35 (\text{total}) - 3 (\text{co-primary}) = 32$ cases. These occurred 2–3 weeks later, fitting the incubation period timeline. $$\text{SAR} = \frac{32}{99} \times 100 = \mathbf{32.32\%} \approx \mathbf{33.3\%} \text{ (closest option provided)} $$ **3. Why other options are incorrect** * **A (35%):** Incorrectly includes the 3 co-primary cases in the numerator and uses the total population (100) as the denominator. * **C (32%):** Uses the correct numerator (32) but incorrectly uses 100 as the denominator instead of the 99 susceptible contacts. * **D (36.5%):** Result of mathematical errors or including the primary case in the numerator. **Clinical Pearls for NEET-PG:** * **Denominator Rule:** Always subtract the primary case(s) from the total population to find the "susceptible contacts." * **Co-primary cases:** Cases occurring within the minimum incubation period of the primary case are excluded from the numerator. * **Measles SAR:** In a totally susceptible population, the SAR of measles is typically >90%. * **Utility:** SAR is used to evaluate the effectiveness of control measures (like isolation or ring vaccination).

Question 1019: The usefulness of a screening test in a community depends on its:

A. Sensitivity
B. Specificity
C. Reliability
D. Predictive value (Correct Answer)

Explanation: **Explanation:** The usefulness of a screening test in a community or clinical setting is primarily determined by its **Predictive Value**. While sensitivity and specificity are inherent properties of the test itself, the predictive value tells us how well the test performs in a real-world population. 1. **Why Predictive Value is Correct:** Predictive value (Positive and Negative) indicates the probability that a patient actually has (or does not have) the disease given a specific test result. In a community setting, the **Positive Predictive Value (PPV)** is the most critical metric because it determines the "yield" of the screening program—i.e., how many people flagged as "positive" truly require further diagnostic workup and treatment. 2. **Why Other Options are Incorrect:** * **Sensitivity and Specificity:** These are **intrinsic properties** of a test. They do not change based on the population being tested. While they determine the test's accuracy, they do not account for the **prevalence** of the disease, which is a key factor in community application. * **Reliability (Precision):** This refers to the ability of a test to give consistent results when repeated under the same conditions. While necessary for a good test, it does not measure the clinical usefulness or diagnostic power in a population. **High-Yield NEET-PG Pearls:** * **Prevalence Connection:** Predictive value is heavily dependent on the prevalence of the disease. If prevalence increases, PPV increases and NPV decreases. * **Sensitivity vs. Specificity:** Sensitivity is used to "Rule Out" disease (SnNout), while Specificity is used to "Rule In" disease (SpPin). * **Screening Goal:** For a rare disease in a community, a test with high specificity is often preferred to minimize false positives and avoid overwhelming the healthcare system.

Question 1020: What is the definition of 'lead time' in epidemiology?

A. The time between disease onset and the first critical diagnosis.
B. The time between disease onset and the first possible point of detection.
C. The time between the first possible point of detection and a final critical point.
D. The time between the first possible point of detection and the usual time of diagnosis. (Correct Answer)

Explanation: **Explanation:** **Lead time** is a fundamental concept in screening programs. It refers to the period by which the diagnosis of a disease is advanced because of a screening test, compared to the time the diagnosis would have been made if the patient had waited for clinical symptoms to appear. 1. **Why Option D is Correct:** In the natural history of a disease, there is a point where a test can first detect the condition (the **first possible point of detection**). Without screening, the patient would only be diagnosed later when symptoms manifest (the **usual time of diagnosis**). The interval between these two points is the lead time. By identifying the disease during this window, we aim to intervene earlier and improve the prognosis. 2. **Why Other Options are Incorrect:** * **Option A & B:** These refer to the **Pre-clinical phase**. The time from disease onset to detection is part of the biological progression, but "lead time" specifically requires a comparison between screening detection and symptomatic detection. * **Option C:** This describes the **Screenable Period** (or the window of opportunity). The "final critical point" is the moment beyond which therapy becomes ineffective. 3. **High-Yield NEET-PG Pearls:** * **Lead Time Bias:** This occurs when screening makes it *appear* as though survival time has increased, when in reality, we simply diagnosed the disease earlier without changing the eventual date of death. * **Length Bias:** Screening tends to detect slowly progressing cases (which have a longer lead time) more easily than rapidly progressing, aggressive cases. * **Ideal Screening Disease:** A disease with a long lead time and an effective early intervention (e.g., Carcinoma Cervix).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free